Totals
- Total revenue
- $953,957
- Total expenses
- $917,443
- Contributions and grants received
- $432,998
- Grants paid
- $218,916
- Program service revenue
- $365,762
- Investment income
- $134,767
- Other revenue
- $20,430
- Total assets, end of year
- $5,636,598
- Total liabilities, end of year
- $173,967
- Net assets or fund balances, end of year
- $5,462,631
- Program services expenses (Part IX)
- $673,444
- Management and general expenses
- $231,624
- Fundraising expenses
- $12,375
- Program service expenses (Part III)
- $673,444
Program services were 73.4% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1c · Fundraising events
$172,578
-
1d · Related organizations
$260,420
-
2a · Program service revenue: SUBSCRIPTION CONTRACT
total $268,812 · related or exempt $268,812
-
2b · Program service revenue: WILEY AGREEMENT
total $96,950 · related or exempt $96,950
-
3 · Investment income
total $149,198 · excluded $149,198
-
7b · Less cost or other basis and sales expenses
securities $14,431
-
7c · Gain or loss
securities -$14,431
-
7d · Net gain or loss
total -$14,431 · related or exempt -$14,431
-
8a · Fundraising events: gross income
$0
-
8a · Fundraising events: contributions included on line 1c
$172,578
-
8b · Fundraising events: direct expenses
$0
-
8c · Net income from fundraising events
total $0
-
11a · Other revenue: RETURN OF UNUSED GRANT
total $20,430 · related or exempt $20,430
-
11e · Other revenue, total
$20,430
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $218,916 · program services $218,916
-
7 · Other salaries and wages
total $188,836 · program services $84,977 · management and general $103,859
-
10 · Payroll taxes
total $17,996 · program services $8,098 · management and general $9,898
-
11b · Fees: legal
total $8,923 · management and general $8,923
-
11c · Fees: accounting
total $10,000 · management and general $10,000
-
11f · Fees: investment management
total $9,792 · management and general $9,792
-
11g · Fees: other
total $418,226 · program services $329,581 · management and general $84,422 · fundraising $4,223
-
13 · Office expenses
total $759 · management and general $759
-
14 · Information technology
total $934 · management and general $934
-
23 · Insurance
total $3,037 · management and general $3,037
-
24a · Other expenses: MERIT
total $16,495 · program services $16,495
-
24b · Other expenses: FIT
total $15,377 · program services $15,377
-
24c · Other expenses: FUNDRAISING
total $8,152 · fundraising $8,152
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $718,763 · end of year $318,519
-
3 · Pledges and grants receivable
beginning of year $14,524 · end of year $16,500
-
4 · Accounts receivable
end of year $7,995
-
9 · Prepaid expenses and deferred charges
end of year $2,586
-
11 · Investments: publicly traded securities
beginning of year $4,503,377 · end of year $5,290,998
-
17 · Accounts payable and accrued expenses
beginning of year $229,370 · end of year $173,967
-
27 · Net assets without donor restrictions
beginning of year $4,983,065 · end of year $5,431,824
-
28 · Net assets with donor restrictions
beginning of year $24,229 · end of year $30,807
Mission and programs · 2025
Mission
ADVANCE HUMAN HEALTH BY SUPPORTING AND DISSEMINATING PHARMACOTHERAPEUTIC AND CLINICAL PHARMACY RESEARCH, SCHOLARSHIP, AND PRACTICE INNOVATION.
-
SUBSCRIPTION SUPPLEMENTS AND PUBLICATION SUBSCRIPTIONS - ORGANIZATION PUBLISHES TWO SCIENTIFIC JOURNALS THAT CONTAIN CLINICAL RESEARCH ARTICLES AND PROVIDE EVALUATION OF DRUGS AND DRUG TREATMENTS.
Expenses $454,528 · Revenue $371,761
-
RESEARCH GRANTS - PROVIDE RESEARCH GRANTS AND AWARDS TO SUPPORT CLINICAL PHARMACY RESEARCH.
Expenses $218,916 · Grants $218,916
As filed on the 2025 return.
Listed in Part VII
-
JAMES E TISDALE PHARM D FCCP BCPS
CHAIR
- Total calculated
- $0
- Hours/week
- 2
-
MICHAEL S MADDUX PHARM D FCCP
EX OFFICIO MEMBER
- Total calculated
- $0
- Hours/week
- 1 + 40 related
-
WILLIAM A MILLER PHARM D FCCP
DIRECTOR
- Total calculated
- $2,500
- From this org
- $2,500
- From related orgs
- $0
- Other
- $0
- Hours/week
- 1
-
C LINDSAY DEVANE PHARM D FCCP
EX OFFICIO MEMBER
- Total calculated
- $0
- Hours/week
- 1
-
KERI A SIMS PHARM D BCPS CAE
SECRETARY
- Total calculated
- $207,899
- From this org
- $137,205
- From related orgs
- $58,802
- Other
- $11,892
- Hours/week
- 30 + 10 related
Schedule J breakdown matched by us
- Base
- $137,205 + $58,802 related
- Bonus
- $0
- Other
- $0
- Deferred
- $10,137
- Nontaxable benefits
- $1,755
- Filer's total
- $149,097 + $58,802 related
-
TITILOLA M AFOLABI PHARMD FCCP
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
KELLY E CAUDLE PHARMD PHD FCC
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
CANDICE L GARWOOD PHARMD FCCP B
EX OFFICIO DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
MARC H SCHEETZ PHARMD FCCP
TREASURER
- Total calculated
- $0
- Hours/week
- 1
-
KATIE J SUDA PHARMD FCCP
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
MARK S SHAEFER
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
STUART T HAINES JACCP EDITOR-IN-CHI
EX OFFICIO DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
SHELDON G HOLSTAD PHARMD
ASSOC. EXE DIRECTOR
- Total calculated
- $353,258
- From this org
- $63,315
- From related orgs
- $253,261
- Other
- $36,682
- Hours/week
- 8 + 32 related
Schedule J breakdown matched by us
- Base
- $63,315 + $253,261 related
- Bonus
- $0
- Other
- $0
- Deferred
- $34,999
- Nontaxable benefits
- $1,683
- Filer's total
- $99,997 + $253,261 related
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
None.
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
- 8 · Paid under the initial-contract exception
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
GRANTS AND AWARDS
-
GRANTS AND AWARDS
-
GRANTS AND AWARDS
-
GRANTS AND AWARDS
-
GRANTS AND AWARDS
Related organizations on this return
Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.
-
AMERICAN COLLEGE OF CLINICAL PHARMACY
501(C)(6) · PROMOTE QUALITY CLINICAL PHARMACY PRACTICE · MO
Provenance
- Return type
- form_990
- Tax year
- 2025
- Filed
- 13 August 2026
- IRS schema version
- 2025v4.2
- Source object
- 202642259349301249
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.